Colorectal Cancer Clinical Trials in Baltimore

Showing 361-373 of 373 trials

DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

NCT00024401

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DHA-paclitaxel in treating patients who have metastatic colorectal cancer.

Colorectal Cancer

TheradexStarted May 2001

Tucson, Arizona, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +3 more locations

UNKNOWNPhase 3< 1 mile

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

NCT00337389

To compare the progression-free survival time (PFS) in patients treated with 5-FU modulated with CoFactor (plus bevacizumab) to 5-FU modulated with leucovorin (plus bevacizumab) in patients with Metastatic Colorectal Cancer.

Metastatic Colorectal CancerColon CancerRectal Cancer

Mast Therapeutics, Inc.1,200 participantsStarted May 2006

Florence, Alabama, United States • Anaheim, California, United States • Apple Valley, California, United States +44 more locations

DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Colorectal Cancer Trials in Other Cities

Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Study of XL281 in Adults With Solid Tumors

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Other Conditions in Baltimore